e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
COPD treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
NT-proBNP in assessment of pulmonary hypertension in COPD patients
M. Grabicki, H. Batura-Gabryel, B. Kuznar-Kaminska, B. Brajer-Luftmann (Poznan, Poland)
Source:
Annual Congress 2013 –COPD treatment
Session:
COPD treatment
Session type:
Thematic Poster Session
Number:
3677
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Grabicki, H. Batura-Gabryel, B. Kuznar-Kaminska, B. Brajer-Luftmann (Poznan, Poland). NT-proBNP in assessment of pulmonary hypertension in COPD patients. Eur Respir J 2013; 42: Suppl. 57, 3677
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Co-morbidities and pulmonary arterial hypertension (PAH) in COPD patients
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
The prevalence and characteristics of pulmonary hypertension in severe COPD
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
Pulmonary hypertension (PH) in chronic obstructive pulmonary disease (COPD): Preliminary data of a longitudinal survey
Source: International Congress 2014 – Clinical presentations
Year: 2014
Pulmonary hypertension and COPD: Clinical assessment and biomarkers
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013
Conclusion: treatment of pulmonary hypertension in COPD patients
Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange
Year: 2005
Acute and chronic effects of PDE5-Is on SpO2 in patients with COPD associated pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013
COPD and clinical phenotypes: Patients with concomitant pulmonary hypertension may be less likely to be frequent exacerbators
Source: International Congress 2014 – Clinical presentations
Year: 2014
Secondary pulmonary hypertension in patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 348s
Year: 2007
Pulmonary embolism in COPD patients
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Prevalence of pulmonary hypertension among COPD patients: screening by echocardiography and NT-PROBNP
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009
Echocardiographic assessment of cardiac function in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
microRNA profile in COPD patients with and without pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
Diagnosis and treatment of secondary pulmonary hypertension in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 404s
Year: 2006
CT predictors of pulmonary hypertension in patients with severe COPD
Source: International Congress 2018 – Evaluation of COPD and various diseases by different imaging modalities
Year: 2018
Usefulness of admission red cell distribution Width as a predictor of early mortality in patients with severe exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Usefulness of FVC/DLCO ratio to stratify the risk of mortality in patients with pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016
Osteoporosis, sarcopenia and pulmonary hypertension in relation to GOLD classification vs BODE index in COPD
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013
Does pulmonary hypertension exclude pulmonary rehabilitation in patients with COPD?
Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases
Year: 2017
Pulmonary diffusing capacity and the risk of fractures in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD markers
Year: 2014
Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept